sustainability of such processes—however, I believe that if created, such bodies would offer a decent start to solving some of these ethical dilemmas, and they would be able to refine their deliberative processes as ARV scale-up progresses.

Finally, as stated above, the provision of treatment should not be delayed in the name of perfecting the decision-making process or in the name of finding the best ethical theories to support pragmatic decisions. Even if a decision makes moral sense, it may be difficult or impossible to implement it on the ground. I strongly believe that making concrete attempts to anticipate and address ethical problems will make for more effective and equitable programs, as will a commitment to reconsidering and refining these ethical hurdles as the programs progress. However, while ethical principles and ethical deliberation are most important, they should not used as an excuse to delay or prevent the implementation of lifesaving treatment—saving any life is better than saving none.

REFERENCES

Associated Press. 2004. Lives at Risk as HIV Drug Runs Out. [Online]. Available: http://www.guardian.co.uk/aids/story/0,7369,1140403,00.html [accessed September 2, 2004].

Attawell K, Mundy J. 2003. WHO, UK Department for International Development. Provision of Antiretroviral Therapy in Resource-Limited Settings: A Review of the Literature up to August 2003. [Online]. Available: http://www.who.int/3by5/publications/documents/en/ARTpaper_DFID_WHO.pdf [accessed September 2, 2004].


Benatar S. 2002. The HIV/AIDS pandemic: A sign of instability in a complex global system. Journal of Medicine and Philosophy 27(2):163–177.


Calabresi G, Bobbit P. 1978. Tragic Choices. New York: W.W. Norton.


Daniels N. 1985. Just Health Care. Cambridge, England: Cambridge University Press.

DELIVER. 2002. The Importance of Logistics in HIV/AIDS Programs, No Product? No Program! [Online]. Available: http://www.deliver.jsi.com/pdf/factsheets/LogHIV.pdf [accessed September 2, 2004].


Houston S. 2002. Justice and HIV care in Africa: Antiretrovirals in perspective. Journal of the International Association of Physicians in AIDS Care 1(2):46–50.


Marlink R. 2003. The Promise the Fear: Tanzania. Paper presented at the Harvard School of Public Health Symposium. [Online]. Available: http://www.hsph.harvard.edu/hai/conferences_events/Recurrent/harvard_symposium/hp2_pres_pdfs/marlink.pdf [accessed September 2, 2004].

McCoy D. 2003a. HIV Care and Treatment in Southern Africa: Addressing Equity. Harare: Equinet and Oxfam GB. (Equinet Discussion Paper Number 10).

McCoy D. 2003b. Health Sector Responses to HIV/AIDS and Treatment Access in Southern Africa: Addressing Equity. Health Systems Trust. (Equinet Discussion Paper Number 10).

McCoy D, Loewenson R. 2004. Access to antiretroviral treatment in Africa: New resources and sustainable health systems are needed. British Medical Journal 328(7434):241–242.

Mill JS. 1863. Utilitarianism. London: Parker, Sun and Bourn.


Nozick R. 1974. Anarchy, State and Utopia. New York: Basic Books.


Partners in Health. 2004. Learn from Haiti. [Online]. Available: http://www.pih.org/inthenews/011206nytimes_op-ed/index.html [accessed February 12, 2004].



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement